-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Diabetes is the most common metabolic disorder, and type 2 diabetes (T2DM) accounts for more than 90% of all diabetes.
The International Diabetes Federation of Diabetes (IDF) estimates that by 2045, the number of diabetic patients in the world will rise from 425 million in 2017 to 629 million.
In view of the increasing incidence of obesity, more and more young and middle-aged people have been diagnosed with T2DM in the past 30 years .
As the age of diagnosis continues to get younger, researchers have also turned their attention to young and middle-aged T2DM patients.
medsci.
This is a wake-up call for those office workers who are not young, eat intemperately, do not want to exercise, and just want to "Ge You Lie" after get off work.
This Kailuan study aims to explore the relationship between the age of onset of type 2 diabetes and cardiovascular disease (CVD) and all-cause mortality in the Chinese population.
Experimental design flow chart
Experimental design flow chartDuring the follow-up period, 11384 participants were diagnosed with T2DM.
The results showed that during the 5.
Compared with matched control subjects, participants who were diagnosed with T2DM before the age of 45 had the highest relative risk of CVD and all-cause death.
Among them, the risk of cardiovascular disease increased by 221% (AHRs=3.
Cardiovascular and death risk ratios in different age groups at diagnosis of T2DM
Cardiovascular and death risk ratios in different age groups at diagnosis of T2DMThe researchers pointed out that the relative risks of cardiovascular disease and all-cause mortality in the age group of T2DM are different, and these associations are more obvious in the onset of young T2DM, which is important for determining the time for clinical decision-making and risk factor intervention under the guidance of guidelines.
The relative risks of cardiovascular disease and all-cause mortality in the age group of T2DM are different, and these associations are more obvious in the onset of young T2DM.
In summary, the age at diagnosis of T2DM has an important prognostic effect on survival and cardiovascular risk.
references:
diabetesjournals.
diabetesjournals.
Leave a message here
